-
2
-
-
26444458845
-
Advances in malignant mesothelioma
-
Robinson BW, Lake RA. Advances in malignant mesothelioma. N Engl J Med 2005; 353: 1591-603.
-
(2005)
N Engl J Med
, vol.353
, pp. 1591-1603
-
-
Robinson, B.W.1
Lake, R.A.2
-
3
-
-
0031038316
-
The role of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma
-
Renshaw AA, Dean BR, Antman KH, et al. The role of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma. Chest 1997; 111: 106-9.
-
(1997)
Chest
, vol.111
, pp. 106-109
-
-
Renshaw, A.A.1
Dean, B.R.2
Antman, K.H.3
-
4
-
-
20244382239
-
The separation of benign and malignant mesothelial proliferations
-
Churg A, Colby TV, Cagle P, et al. The separation of benign and malignant mesothelial proliferations. Am J Surg Pathol 2000; 24: 1183-200.
-
(2000)
Am J Surg Pathol
, vol.24
, pp. 1183-1200
-
-
Churg, A.1
Colby, T.V.2
Cagle, P.3
-
5
-
-
45149084771
-
Malignant pleural mesothelioma: ESMO clinical recommendations for diagnosis, treatment and follow-up
-
Stahel RA, Weder W, Felip E. Malignant pleural mesothelioma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2008; 19 (Suppl 2): ii43-4.
-
(2008)
Ann Oncol
, vol.19
, Issue.SUPPL. 2
-
-
Stahel, R.A.1
Weder, W.2
Felip, E.3
-
6
-
-
69149105448
-
Guidelines for pathologic diagnosis of malignant mesothelioma: A consensus statement from the International Mesothelioma Interest Group
-
Husain AN, Colby TV, Ordonez NG, et al. Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med 2009; 133: 1317-31.
-
(2009)
Arch Pathol Lab Med
, vol.133
, pp. 1317-1331
-
-
Husain, A.N.1
Colby, T.V.2
Ordonez, N.G.3
-
7
-
-
0027315218
-
Thoracoscopy in pleural malignant mesothelioma: A prospective study of 188 consecutive patients. Part 1: Diagnosis
-
Boutin C, Rey F. Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 1: Diagnosis. Cancer 1993; 72: 389-93.
-
(1993)
Cancer
, vol.72
, pp. 389-393
-
-
Boutin, C.1
Rey, F.2
-
8
-
-
50049122654
-
The comparative accuracy of different pleural biopsy techniques in the diagnosis of malignant mesothelioma
-
Attanoos RL, Gibbs AR. The comparative accuracy of different pleural biopsy techniques in the diagnosis of malignant mesothelioma. Histopathology 2008; 53: 340-4.
-
(2008)
Histopathology
, vol.53
, pp. 340-344
-
-
Attanoos, R.L.1
Gibbs, A.R.2
-
9
-
-
44649195806
-
Prophylactic radiotherapy for pleural puncture sites in mesothelioma: The controversy continues
-
Davies HE, Musk AW, Lee YC. Prophylactic radiotherapy for pleural puncture sites in mesothelioma: the controversy continues. Curr Opin Pulm Med 2008; 14: 326-30.
-
(2008)
Curr Opin Pulm Med
, vol.14
, pp. 326-330
-
-
Davies, H.E.1
Musk, A.W.2
Lee, Y.C.3
-
10
-
-
70350294133
-
Prophylactic radiotherapy to intervention sites in mesothelioma: A systematic review and survey of UK practice
-
Lee C, Bayman N, Swindell R, et al. Prophylactic radiotherapy to intervention sites in mesothelioma: a systematic review and survey of UK practice. Lung Cancer 2009; 66: 150-6.
-
(2009)
Lung Cancer
, vol.66
, pp. 150-156
-
-
Lee, C.1
Bayman, N.2
Swindell, R.3
-
11
-
-
0142197139
-
Malignant mesothelioma in Australia, 1945-2002
-
Leigh J, Driscoll T. Malignant mesothelioma in Australia, 1945-2002. Int J Occup Environ Health 2003; 9: 206-17.
-
(2003)
Int J Occup Environ Health
, vol.9
, pp. 206-217
-
-
Leigh, J.1
Driscoll, T.2
-
12
-
-
0034095794
-
The cytology of malignant mesothelioma
-
Whitaker D. The cytology of malignant mesothelioma. Cytopathology 2000; 11: 139-51.
-
(2000)
Cytopathology
, vol.11
, pp. 139-151
-
-
Whitaker, D.1
-
13
-
-
20444363792
-
Asbestos and mesothelioma: Worldwide trends
-
Kazan-Allen L. Asbestos and mesothelioma: worldwide trends. Lung Cancer 2005; 49 (Suppl 1): S3-8.
-
(2005)
Lung Cancer
, vol.49
, Issue.SUPPL. 1
-
-
Kazan-Allen, L.1
-
14
-
-
0003911911
-
-
College of American Pathologists Committee on Nomenclature and Classification of Disease. Chicago: College of American Pathologists
-
College of American Pathologists Committee on Nomenclature and Classification of Disease. Systematized Nomenclature of Pathology. Chicago: College of American Pathologists, 1965.
-
(1965)
Systematized Nomenclature of Pathology
-
-
-
16
-
-
0032907641
-
Fine needle aspiration or core biopsy
-
Britton P. Fine needle aspiration or core biopsy. Breast 1999; 8: 1-4.
-
(1999)
Breast
, vol.8
, pp. 1-4
-
-
Britton, P.1
-
17
-
-
0006288480
-
Cytological appearances of malignant mesothelioma
-
Henderson D, Shilkin K, Langlois S, et al., editors. New York: Hemisphere
-
Whitaker D, Sterrett G, Shilkin K. Cytological appearances of malignant mesothelioma. In: Henderson D, Shilkin K, Langlois S, et al., editors. Malignant Mesothelioma. New York: Hemisphere, 1992; 167-82.
-
(1992)
Malignant Mesothelioma
, pp. 167-182
-
-
Whitaker, D.1
Sterrett, G.2
Shilkin, K.3
-
18
-
-
0025341209
-
Effusion cytology in the diagnosis of malignant epithelioid and biphasic pleural mesothelioma
-
Sherman ME, Mark EJ. Effusion cytology in the diagnosis of malignant epithelioid and biphasic pleural mesothelioma. Arch Pathol Lab Med 1990; 114: 845-51.
-
(1990)
Arch Pathol Lab Med
, vol.114
, pp. 845-851
-
-
Sherman, M.E.1
Mark, E.J.2
-
19
-
-
33745019181
-
Expression of renal cell carcinoma-associated markers erythropoietin, CD10, and renal cell carcinoma marker in diffuse malignant mesothelioma and metastatic renal cell carcinoma
-
Butnor KJ, Nicholson AG, Allred DC, et al. Expression of renal cell carcinoma-associated markers erythropoietin, CD10, and renal cell carcinoma marker in diffuse malignant mesothelioma and metastatic renal cell carcinoma. Arch Pathol Lab Med 2006; 130: 823-7.
-
(2006)
Arch Pathol Lab Med
, vol.130
, pp. 823-827
-
-
Butnor, K.J.1
Nicholson, A.G.2
Allred, D.C.3
-
20
-
-
72149101492
-
Evidence-based guidelines to optimize the selection of antibody panels in cytopathology: Pleural effusions with malignant epithelioid cells
-
Westfall DE, Fan X, MarchevskyAM.Evidence-based guidelines to optimize the selection of antibody panels in cytopathology: pleural effusions with malignant epithelioid cells. Diagn Cytopathol 2010; 38: 9-14.
-
(2010)
Diagn Cytopathol
, vol.38
, pp. 9-14
-
-
Westfall, D.E.1
Fan, X.2
Marchevsky, A.M.3
-
21
-
-
0035075293
-
Benign and malignant mesothelial proliferations
-
Koss LG. Benign and malignant mesothelial proliferations. Am J Surg Pathol 2001; 25: 548-9.
-
(2001)
Am J Surg Pathol
, vol.25
, pp. 548-549
-
-
Koss, L.G.1
-
22
-
-
33746605601
-
The high post-test probability of a cytological examination renders further investigations to establish a diagnosis of epithelial malignant pleural mesothelioma redundant
-
Aerts JG, Delahaye M, van der Kwast TH, et al. The high post-test probability of a cytological examination renders further investigations to establish a diagnosis of epithelial malignant pleural mesothelioma redundant. Diagn Cytopathol 2006; 34: 523-7.
-
(2006)
Diagn Cytopathol
, vol.34
, pp. 523-527
-
-
Aerts, J.G.1
Delahaye, M.2
Van Der Kwast, T.H.3
-
23
-
-
33645275721
-
Evaluation of 12 antibodies for distinguishing epithelioid mesothelioma from adenocarcinoma: Identification of a three-antibody immunohistochemical panel with maximal sensitivity and specificity
-
Yaziji H, Battifora H, Barry TS, et al. Evaluation of 12 antibodies for distinguishing epithelioid mesothelioma from adenocarcinoma: identification of a three-antibody immunohistochemical panel with maximal sensitivity and specificity. Mod Pathol 2006; 19: 514-23.
-
(2006)
Mod Pathol
, vol.19
, pp. 514-523
-
-
Yaziji, H.1
Battifora, H.2
Barry, T.S.3
-
24
-
-
33845341114
-
What are the current best immunohistochemical markers for the diagnosis of epithelioid mesothelioma? A review and update
-
Ordonez NG. What are the current best immunohistochemical markers for the diagnosis of epithelioid mesothelioma? A review and update. Hum Pathol 2007; 38: 1-16.
-
(2007)
Hum Pathol
, vol.38
, pp. 1-16
-
-
Ordonez, N.G.1
-
25
-
-
0036122832
-
Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcinoma of the ovary and peritoneum
-
Attanoos RL, Webb R, Dojcinov SD, et al. Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcinoma of the ovary and peritoneum. Histopathology 2002; 40: 237-44.
-
(2002)
Histopathology
, vol.40
, pp. 237-244
-
-
Attanoos, R.L.1
Webb, R.2
Dojcinov, S.D.3
-
26
-
-
0343238145
-
Value of thyroid transcription factor-1, E-cadherin, BG8, WT1, and CD44S immunostaining in distinguishing epithelial pleural mesothelioma from pulmonary and nonpulmonary adenocarcinoma
-
Ordonez NG. Value of thyroid transcription factor-1, E-cadherin, BG8, WT1, and CD44S immunostaining in distinguishing epithelial pleural mesothelioma from pulmonary and nonpulmonary adenocarcinoma. Am J Surg Pathol 2000; 24: 598-606.
-
(2000)
Am J Surg Pathol
, vol.24
, pp. 598-606
-
-
Ordonez, N.G.1
-
27
-
-
0034145199
-
Thyroid transcription factor-1 is a marker of lung and thyroid carcinomas
-
Ordonez NG. Thyroid transcription factor-1 is a marker of lung and thyroid carcinomas. Adv Anat Pathol 2000; 7: 123-7.
-
(2000)
Adv Anat Pathol
, vol.7
, pp. 123-127
-
-
Ordonez, N.G.1
-
28
-
-
0141613691
-
The use of immunohistochemistry in distinguishing reactive from neoplastic mesothelium. A novel use for desmin and comparative evaluation with epithelial membrane antigen, p53, platelet-derived growth factor-receptor, P-glycoprotein and Bcl-2
-
Attanoos RL, Griffin A, Gibbs AR. The use of immunohistochemistry in distinguishing reactive from neoplastic mesothelium. A novel use for desmin and comparative evaluation with epithelial membrane antigen, p53, platelet-derived growth factor-receptor, P-glycoprotein and Bcl-2. Histopathology 2003; 43: 231-8.
-
(2003)
Histopathology
, vol.43
, pp. 231-238
-
-
Attanoos, R.L.1
Griffin, A.2
Gibbs, A.R.3
-
29
-
-
13844252069
-
The value of epithelial membrane antigen expression in separating benign mesothelial proliferation from malignant mesothelioma: A comparative study
-
Saad RS, Cho P, Liu YL, et al. The value of epithelial membrane antigen expression in separating benign mesothelial proliferation from malignant mesothelioma: a comparative study. Diagn Cytopathol 2005; 32: 156-9.
-
(2005)
Diagn Cytopathol
, vol.32
, pp. 156-159
-
-
Saad, R.S.1
Cho, P.2
Liu, Y.L.3
-
30
-
-
43249083136
-
Overexpression and altered glycosylation of MUC1 in malignant mesothelioma
-
Creaney J, Segal A, Sterrett G, et al. Overexpression and altered glycosylation of MUC1 in malignant mesothelioma. Br J Cancer 2008; 98: 1562-9.
-
(2008)
Br J Cancer
, vol.98
, pp. 1562-1569
-
-
Creaney, J.1
Segal, A.2
Sterrett, G.3
-
31
-
-
65349097940
-
Usefulness of EMA, GLUT-1, and XIAP for the cytologic diagnosis of malignant mesothelioma in body cavity fluids
-
Shen J, Pinkus GS, Deshpande V, et al. Usefulness of EMA, GLUT-1, and XIAP for the cytologic diagnosis of malignant mesothelioma in body cavity fluids. Am J Clin Pathol 2009; 131: 516-23.
-
(2009)
Am J Clin Pathol
, vol.131
, pp. 516-523
-
-
Shen, J.1
Pinkus, G.S.2
Deshpande, V.3
-
32
-
-
77952561875
-
The use of immunohistochemistry to distinguish reactive mesothelial cells from malignant mesothelioma in cytologic effusions
-
Hasteh F, Lin GY, Weidner N, et al. The use of immunohistochemistry to distinguish reactive mesothelial cells from malignant mesothelioma in cytologic effusions. Cancer Cytopathol 2010; 118: 90-6.
-
(2010)
Cancer Cytopathol
, vol.118
, pp. 90-96
-
-
Hasteh, F.1
Lin, G.Y.2
Weidner, N.3
-
33
-
-
0021282013
-
Diagnosis of pleural malignant mesothelioma in life - A practical approach
-
Whitaker D, Shilkin K. Diagnosis of pleural malignant mesothelioma in life - a practical approach. J Pathol 1984; 143: 147-75.
-
(1984)
J Pathol
, vol.143
, pp. 147-175
-
-
Whitaker, D.1
Shilkin, K.2
-
35
-
-
0026769458
-
Malignant mesothelioma: Cytologic diagnosis with histologic, immunohistochemical, and ultrastructural correlation
-
Leong AS, Stevens MW, Mukherjee TM. Malignant mesothelioma: cytologic diagnosis with histologic, immunohistochemical, and ultrastructural correlation. Semin Diagn Pathol 1992; 9: 141-50.
-
(1992)
Semin Diagn Pathol
, vol.9
, pp. 141-150
-
-
Leong, A.S.1
Stevens, M.W.2
Mukherjee, T.M.3
-
36
-
-
0026785081
-
Cytopathology of malignant mesothelioma: A stepwise logistic regression analysis
-
Stevens MW, Leong AS, Fazzalari NL, et al. Cytopathology of malignant mesothelioma: a stepwise logistic regression analysis. Diagn Cytopathol 1992; 8: 333-41.
-
(1992)
Diagn Cytopathol
, vol.8
, pp. 333-341
-
-
Stevens, M.W.1
Leong, A.S.2
Fazzalari, N.L.3
-
37
-
-
19644385820
-
Pleural biopsy: A reliable method for determining the diagnosis but not subtype in mesothelioma
-
Bueno R, Reblando J, Glickman J, et al. Pleural biopsy: a reliable method for determining the diagnosis but not subtype in mesothelioma. Ann Thorac Surg 2004; 78: 1774-6.
-
(2004)
Ann Thorac Surg
, vol.78
, pp. 1774-1776
-
-
Bueno, R.1
Reblando, J.2
Glickman, J.3
|